ArticleScientific reports2026
YOLO-LS: a novel deep learning framework for brain tumor segmentation in Magnetic Resonance Imaging.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- SERA-Net: Rethinking CNN Design for Brain Tumor Classification via Squeeze-and-Excite Attention and Residual Learning.Bioengineering (Basel, Switzerland) · 2026Article
- W-AGRU-Net: a dual-stream attention framework for robust brain tumor segmentation in clinical MRI imaging.Scientific reports · 2026Article
- Liver Tumor Segmentation with Deep Learning: A Comparative Analysis of CNN-, Transformer-, and YOLO-Based Models on the ATLAS MRI.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors exhibit high heterogeneity in morphology, texture, and location, making accurate recognition and segmentation critical for clinical diagnosis, surgical planning, and prognosis evaluation. However, manual annotation of MRI scans is hindered by subjective bias and inefficiency. Furthermore, existing automated frameworks often face a trade-off between segmentation precision-particularly at infiltrative boundaries-and the computational efficiency required for deployment in resource-constrained environments. To address these challenges, this study proposes YOLO-LS (Lightweight Segmentation), an enhanced framework based on the YOLO11n-seg architecture designed for efficient detection and high-precision segmentation of brain tumors. The methodology introduces three key innovations: (1) integrating ShuffleNet V1 as a lightweight backbone to significantly reduce parameter count and computational complexity via pointwise grouped convolutions; (2) incorporating the DySample dynamic upsampling mechanism to mitigate the loss of fine-grained semantic details inherent in traditional interpolation, thereby improving the recovery of tumor boundaries; and (3) optimizing the neck network with a C3k2-PoolingFormer module to facilitate efficient cross-scale feature fusion and global context capture. The model was trained and tested on the Figshare dataset (3,064 images) using five-fold cross-validation and externally validated on an independent Kaggle dataset (300 images). Results demonstrate that YOLO-LS achieved a bounding box mAP50 of 0.953 ± 0.011, a Dice coefficient of 0.91 ± 0.01, and a 95% Hausdorff Distance (HD
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.